Most beneficiaries happy to get a vaccine, but some still doubtful…
Covishield appears the preferred vaccine, with Covixn clinical trial data not fully available, yet
Read More
Covishield appears the preferred vaccine, with Covixn clinical trial data not fully available, yet
Read More